Skip Navigation LinksHome > April 2014 - Volume 19 - Issue 2 > Treating the donor
Current Opinion in Organ Transplantation:
doi: 10.1097/MOT.0000000000000059

Treating the donor

McKeown, Dermot W.a; Ball, Jonathanb

Collapse Box


Purpose of review: Current pressures of organ supply and demand require maximization of potential for organ donation. The donor population is older and has more significant comorbidity than in the past.

Optimal management of the donor after brain death (DBD) is essential to ensure that the greatest number of organs can be transplanted per donor. Defining evidence-based drugs and techniques to assist this has never been more important.

Recent findings: Care of patients with catastrophic brain injury incorporating supportive therapy targeted at specific goals and delivered by experienced specialists provides the best donation outcomes. Such pathways represent best practice critical care applied to this population. In this context, the value of some previously recommended therapies appears questionable and warrants reassessment. Prolonged (>24 h) incorporeal organ conditioning may have significant benefits.

Extracorporeal support in the resuscitation arena is emerging and, in patients who fail to respond, may yield a new source of donors.

Summary: Early identification of potential DBD, best practice critical care, and achieving defined treatment goals are associated with more transplantable organs.

Study of a complex intervention like donor management presents significant problems of organization, ethics and consent. This situation is recognized internationally and progress is being made.

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.